Drug Profile
Fluorine 18 MNI 968
Alternative Names: [18F]MNI 968; PF 06730110Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Molecular NeuroImaging
- Class Diagnostic agents; Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neurodegenerative disorders
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for phase-I development in Neurodegenerative-disorders(Diagnosis, In volunteers) in USA (Parenteral, Injection)
- 01 May 2017 Phase-I clinical trials in Neurodegenerative disorders (Diagnosis, In volunteers) in USA (Parenteral) (NCT03142724)
- 03 Mar 2017 Phase-0 for Neurodegenerative disorders (Diagnosis) in USA (Parenteral) (NCT03082768)